Medical Paper:
Are you a global patient seeking access to traditional Chinese medicine (TCM) prescriptions mentioned in academic literature? Look no further! Our comprehensive service bridges the gap between research and practice, offering seamless access to TCM prescriptions tailored to your needs.
We understand the challenges international patients face in accessing TCM treatments recommended in scholarly articles. Our dedicated team facilitates every step of the process, from connecting you with experienced TCM practitioners to fulfilling your herbal prescription needs.
Here's how our service works:
-
Expert Consultation: We match you with knowledgeable TCM doctors proficient in both traditional and modern medical practices.
-
Prescription Procurement: Our team assists in obtaining prescriptions from reputable hospitals and clinics, ensuring adherence to your specific requirements.
-
Herbal Medicine Acquisition: We source high-quality, authentic TCM herbs and compounds, tailored to the prescriptions provided by your chosen practitioner.
-
Convenient Dosage Format: For your convenience, we transform traditional herbal formulas into easy-to-use granules, eliminating the need for complicated decoction processes.
-
Global Delivery: Once prepared, your personalized TCM regimen is shipped directly to your doorstep, wherever you are in the world.
You can trust that your journey towards holistic wellness through TCM is supported by expertise, authenticity, and convenience. Contact us today to explore the benefits of our one-stop solution for accessing traditional Chinese medicine.
Abstract
BACKGROUND: Hepatitis B virus infection is a serious health problem worldwide. Traditional Chinese medicinal herbs have been widely used to treat chronic liver diseases, and many controlled trials have been done to investigate their efficacy. OBJECTIVES: To assess the efficacy and safety of traditional Chinese medicinal herbs for chronic hepatitis B infection. SEARCH STRATEGY: Searches were applied to the following electronic databases: the CHBG Trials Register, the Cochrane Complementary Medicine Field Trials Register, the Cochrane Library, MEDLINE, EMBASE and BIOSIS. Five Chinese journals and conference proceedings were handsearched. No language restriction was used. SELECTION CRITERIA: Randomised or quasi-randomised trials with at least three months follow-up. Trials of Chinese medicinal herbs (single or compound) compared with placebo, no intervention, general non-specific treatment or interferon treatment were included. Trials of Chinese medicinal herbs plus interferon versus interferon alone were also included. Trials could be double-blind, single-blind or not blinded. DATA COLLECTION AND ANALYSIS: Data were extracted independently by two reviewers. The methodological quality of trials was evaluated using the Jadad-scale plus allocation concealment. Intention-to-treat analyses were performed. MAIN RESULTS: Nine randomised trials, including 936 patients, met the inclusion criteria. Methodological quality was considered adequate in only one trial. There was a significant funnel plot asymmetry (regression coefficient=3.37, standard error 1.40, P=0.047). Ten different medicinal herbs were tested in the nine trials. Compared to non-specific treatment or placebo, Fuzheng Jiedu Tang (compound of herbs) showed significantly positive effects on clearance of serum HBsAg, HBeAg, and HBV DNA; Polyporus umbellatus polysaccharide on serum HBeAg and HBV DNA; Phyllanthus amarus on serum HBeAg. Phyllanthus compound and kurorinone showed no significant effect on clearance of serum HBeAg and HBV DNA and on alanine aminotransferase normalisation compared to interferon treatment. There were no significant effects of the other examined herbs. REVIEWER'S CONCLUSIONS: Some Chinese medicinal herbs may work in chronic hepatitis B. However, the evidence is too weak to recommend any single herb. Rigorously designed, randomised, double-blind, placebo-controlled trials are required.